Exelixis, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-46.8% vs price
Base Case (Median)
-35.1% vs price
Bull Case (75th pct.)
51.0% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $27.02 | -48.4% | High (40%) |
| PE Comparable | $70.99 | 35.7% | Medium (25%) |
| Growth Trajectory DCF | $326.82 | 524.7% | Medium (20%) |
| Graham Number | $23.90 | -54.3% | Medium (40%) |
| EV/EBITDA | $33.94 | -35.1% | Medium (20%) |
| EV/FCF | $86.96 | 66.2% | Medium (20%) |
| Earnings Power Value | $28.67 | -45.2% | Medium (50%) |
Based on 7 out of 8 methods, EXEL appears fairly valued at the current price of $52.32. The base case fair value of $33.94 implies 35.1% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.